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Pseudomonas aeruginosa has developed a complex cell-to-cell communication system that relies on low-molecular weight excreted
molecules to control the production of its virulence factors. We previously characterized the transcriptional regulator MvfR,
that controls a major network of acute virulence functions in P. aeruginosa through the control of its ligands, the 4-hydroxy-2-
alkylquinolines (HAQs)—4-hydroxy-2-heptylquinoline (HHQ) and 3,4-dihydroxy-2-heptylquinoline (PQS). Though HHQ and
PQS are produced in infected animals, their ratios diﬀer from those in bacterial cultures. Because these molecules are critical for the
potency of activation of acute virulence functions, here we investigated whether they are also produced during human P. aeruginosa
acute wound infection and whether their ratio is similar to that observed in P. aeruginosa-infected mice. We found that a clinically
relevant P. aeruginosa isolate produced detectable levels of HAQs with ratios of HHQ and PQS that were similar to those produced
in burned and infected animals, and not resembling ratios in bacterial cultures. These molecules could be isolated from wound
tissue as well as from drainage liquid. These results demonstrate for the first time that HAQs can be isolated and quantified from
acute human wound infection sites and validate the relevance of previous studies conducted in mammalian models of infection.
1. Introduction
Emerging multi-drug resistant organisms are major contrib-
utors to morbidity and mortality following burn injury [1].
Pseudomonas aeruginosa infections are common following
burns, often presenting as wound infections [2–4]. Current
prophylactic measures intended to prevent these infections
in burn patients consist of isolation and use of strict sterile
techniques combined with rapid surgical wound closure.
Although these prevention eﬀorts can be eﬀective under ideal
circumstances, they often fail due to insuﬃcient nursing,
anesthesia, and critical care management resources, insuﬃ-
cient donor sites for immediate wound closure, or spread of
infection from the surrounding environment during the ini-
tial first aid provided [5]. Treatment of Pseudomonas wound
infections, along with the frequently associated shock and
respiratory failure, can involve complex fluid and ventilator
management, definitive surgical debridement, and advanced
wound closure technologies. The use of antimicrobial agents
such as colistin (polymyxin E), tailored to navigate the most
recent antibiotic resistance pattern, has been useful.
Clearly, new innovations for the prevention and treat-
ment of Pseudomonas wound infections in burn patients are
needed. Ongoing basic research eﬀorts have made strides in
dissecting the pathogenesis of Pseudomonas infections using
various models of infections in plants, flies, and mice [6–10].
P. aeruginosa coordinates the expression of multiple viru-
lence factors using a complex regulatory communication
system, namely, Quorum Sensing (QS), which has been
shown to control approximately 10% of P. aeruginosa genes
[11, 12]. QS is a cell-density-dependent phenomenon based
on the release of low-molecular weight molecules that
coordinate gene expression in a cell population [11, 13, 14].
In response to population density, P. aeruginosa produces
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and secretes such molecules, some of which act as specific
chemical signals that control the production of virulence
factors mediating acute infection.
A decade ago, we identified the QS transcriptional
regulator MvfR (multiple virulence factors regulator) [9].
TheMvfR protein controls the expression ofmost of P. aerug-
inosa’s acute virulence-associated factors [15] as well as the
biosynthesis of more than 60 excreted anthranilic acid (AA)
low-molecular weight derivatives, most of which belong to
the 4-hydroxy-2-alkylquinolines (HAQs) family [12, 13, 16].
HAQ expression is subject to positive autoregulation, with
two HAQs, namely, 4-hydroxy-2-heptylquinoline (HHQ)
[17] and 3,4-dihydroxy-2-heptylquinoline (PQS) [18], func-
tioning as MvfR ligands. These HAQs, in concert with MvfR,
positively regulate the transcription of the pqsABCD [19]
and phnAB [9] operons, which encode HAQ biosynthetic
enzymes of these molecules [9, 15, 19]. PQS and HHQ are
produced in vitro and in vivo in acute models of infection
[9, 11, 15, 19]. We showed previously that PQS is more
potent thanHHQ in inducingMvfR binding to the pqsA pro-
moter as well as inducing pqsA-E transcription in pqsA::pqsH
P. aeruginosa mutant [19]. The relative potency of HHQ
versus PQS in inducingMvfR ligand-binding domain precip-
itation suggests that these molecules induce diﬀerent MvfR
conformational changes; a diﬀerence in conformation eﬀects
could subsequently results in diﬀerent binding aﬃnities to
the same MvfR target promoters, and diﬀerences in MvfR-
regulated gene transcription.
Because HAQs govern and dictate infection course, they
may be of use as indicators of infection stage. Moreover,
interfering with these molecules could be a means by
which to control Pseudomonas infections. The production of
Pseudomonas HAQs has yet to be studied in human wounds.
Therefore, here, we examined for the first time whether
clinically important Pseudomonas specimens, derived from
an active burn wound infection in a human patient, produce
and excrete detectable levels HAQs in situ.
2. Materials and Methods
2.1. Human Samples. Permission for use of excess tissue and
wound drainage material for the purposes of this study and
permission for medical record review were obtained from
the hospital institutional review board. The samples were
obtained from a discarded resected infected burn wound on
the patient right leg. Three types of specimen were collected:
(i) one containing necrotic muscle with fat; (ii) one wet and
oozing sample with pus and liquefied fat mixed together with
some saline solution from the operative field; finally (iii)
drainage liquid collected out from the wound.
2.1.1. Histology. Wound biopsies were performed for the
purposes of diagnosis and therapy at the time of surgery in
the course of the patient’s treatment. The biopsy specimens
were fixed in formalin, blocked in paraﬃn, and stained with
hematoxylin and eosin. Wound drainage and resected tissues
in excess of the amount required for the biopsy were used in
this analysis.
2.1.2. HAQ Determination. The analyzed samples were
obtained from excess material. Tissues were weighed, cut
into small pieces, and then homogenized in 50% methanol.
Whenever appropriate, liquid was mixed 1 : 1 with 50%
methanol. The quantification of HAQs was performed by
liquid chromatography/mass spectrometry (LC/MS) as
described elsewhere [20], using HHQ-D4 and PQS-D4 as
internal standards. Positive electrospray was employed in
MRM mode with 2 × 10−3 mTorr argon and as the collision
gas and 30V of energy to quantify HAQs by LC/MS. The
following ion transitions were used: HHQ 244>159, HHQ-
D4 248>163, HQNO 260>159, PQS 260>175, and PQS-D4
264>179.
3. Results and Discussion
3.1. Case Report. A 17-year-old previously healthy male
touched a high voltage wire in Honduras. He sustained burns
to 58% of his total body surface area (TBSA), including
partial thickness burns to his face, both arms, back, and
buttocks, with full thickness injury to his right lower leg and
medial left thigh. His initial treatment at two diﬀerent hospi-
tals in Honduras included right lower extremity fasciotomies
and multiple dressing changes. He received clindamycin,
meropenem, and amikacin for an unknown period of time.
He was transferred to the Shriners Boston Burns Hospital 9
days after sustaining the original injury.
Upon admission to Shriners Hospital, the patient was
awake and alert but mildly febrile and tachycardic. There was
a strong odor from his dressings. He was taken immediately
to the operating room for debridement and stabilization.
His lower extremity wounds were grossly infected with
deep necrotic wounds to the right lower extremity where
eschar had been partially resected. Biopsies showed diﬀuse
inflammatory infiltrate and intramuscular rod-shaped bac-
teria (Figure 1(a)). Cultures from the right lower extremity
revealed three P. aeruginosa isolates, a pan-resistant Ac-
inetobacter baumannii, Klebsiella pneumoniae, Clostridium
species, and Candida krusei. Initially, the Pseudomonas
was susceptible to aztreonam, ciprofloxacin, levofloxacin,
piperacillin/sulbactam, colistin; and it was resistant to
amikacin, cefepime, gentamycin, meropenem, ticarcillin,
tobramycin, and imipenem. Pseudomonas specimens from
the central line tip that the patient came in with were also
grown in culture. The patient was treated initially with van-
comycin and meropenem as well as topical mafenide acetate.
He underwent serial operative debridements over the next
month. The wounds were eventually closed with autografts.
He was discharged after a 2.5-month-long hospitalization.
3.2. Assessment of HAQs. P. aeruginosa acute burn wound
infection is characterized by the presence of a diﬀuse inflam-
matory infiltrate related to muscle necrosis (Figure 1(a)),
together with intracellular rode shaped bacteria (Figure 1(b)
+ inset). Bacteria-induced muscle necrosis and the bacteria’s
ability to invade muscle cells are two phenotypic charac-
teristics that strongly rely on the coordinated expression of
several bacterial virulence factors, many of which are under
the control of MvfR [17]. We thus sought to determine the
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Figure 1: High levels of HAQs are produced in P. aeruginosa infected burn wounds. (a) Hematoxylin and eosin stained sections of right lower
extremity biopsy specimen demonstrating active deep infection with myonecrosis and inflammatory infiltrate (10x) (b) Oil immersion view
of the same specimen demonstrating myonecrosis with proliferating rods. Note the presence of intramuscular bacteria (inset). HHQ, PQS
and HQNO levels measured in two operative specimens, necrotic muscle with fat (c) and pus and liquefied fat (d); and from the collected
drainage liquid (e) obtained from an infected burn wound on the patient’s right leg. Notably, HAQs were detected in the drainage liquid at
a magnitude similar to that encountered in bacterial broth cultures.
major MvfR ligands that are produced during burn wound
infection in humans. As shown in Figures 1(c) and 1(d),
we detected HHQ, PQS, and HQNO in whole muscle tissue
as well as in drainage liquid. Interestingly, HHQ levels were
higher than PQS levels. This result corroborates the ratios
of these molecules that we measured previously in muscle
biopsies from burned and P. aeruginosa infected mice [17],
and are in sharp contrast to ratios measured in bacterial cell
cultures [12, 13, 21], indicating that the “in vitro” bacterial
culture setting does not reflect accurately the in vivo burn
wound situation. Thus, in agreement with our previous
results in burned and infected animals [17], we found that
HHQ is produced at high levels in human burn wounds
and not fully converted into PQS. PQS is converted from its
precursor HHQ by the enzyme PqsH [22], whose activity is
regulated by the homoserine lactone regulator LasR [22]. The
low PQS levels observed in both mouse and human infected
tissues might be due to reduced PqsH activity in vivo. Never-
theless, we have shown that PQS is fully dispensable in that
pqsH-mutant cells, which produce HHQ but completely lack
PQS, display normal MvfR-dependent gene expression and
virulence in burned and infected mice [17]. Conversely, PQS
is required for full production of the phenazine pyocyanin
[17].
4. Conclusions
The findings presented here show for the first time that
HAQs are produced during acute P. aeruginosa infections in
4 Journal of Pathogens
human burn wounds. Moreover, these findings demonstrate
that HAQs cell-to-cell communication molecules can be
measured directly from an infected patient and that the ratio
between the various HAQ molecule types resembles that
found in burned and infected mice but not that produced
in bacterial cell cultures. These results validate the use of
burnmousemodels in studies of QS-dependent P. aeruginosa
acute infection. The fact that these QS low-molecular-weight
molecules are detected also in drainage liquid collected from
surgical sites is of the utmost importance for several reasons:
(i) it demonstrates that these small molecules can aﬀect
large area of wounds and that in humans the bacteria can
communicate beyond their immediate surroundings; (ii) it
indicates that these molecules might aﬀect other pathogens
in polymicrobial infections [23, 24], such as in the presently
reported case; (iii) it supports the hypothesis that targeting
virulence and QS with selective anti-QS inhibitors may
diminish infections caused by multi-drug resistant bacteria
[10, 25].
The ability to accurately follow bacterial pathogenesis is
an important prerequisite for the development of antivir-
ulence agents aimed at controlling the course of infection.
In this context, QS is a suitable drug target for new anti-
microbials because it controls bacterial pathogenesis and
it is evolutionarily conserved among pathogenic bacteria
[26, 27]. Conventional antibiotics target a narrow spec-
trum of activities that are essential for bacterial growth.
Pharmacological targeting of nonessential functions such
as virulence factor production may decrease the emergence
of resistance since bacterial survival is not directly chal-
lenged or subjected to selection pressure. For instance,
we showed that pharmacologic inhibition of the MvfR
regulon greatly reduced P. aeruginosa virulence in mice
[10].
In conclusion, here we demonstrated that QS signaling
molecules can be measured directly from an infected patient
and that the ratio between the various HAQ molecule types
resembles that found in burned and infected mice, demon-
strating the importance of animal models in the evaluation
of the eﬃcacy of new drugs. These results also strengthen
the validity of the hypothesis that QS inhibition may be an
excellent target to prevent or halt multi-drug resistant P.
aeruginosa infections.
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